Search Results 491-500 of 19480 for B cell lymphomas
Imatinib-responsive hypereosinophilia in a patient with B cell ALL. Leuk Lymphoma. 2004 Dec; 45(12):2497-501. View PubMed; Klion AD, Law MA, Noel P, Kim YJ ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study to Evaluate 68Ga- PSMA-Dual ...
Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma ... b) High-risk disease (stage III/IV, KPI groups 3 ... NK cell leukemia.
... cell lymphoma. Monoclonal antibody-drug conjugates, such as brentuximab vedotin, can block cancer growth in different ways by targeting certain cells.
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma ... * Patient with chronic hepatitis B virus (HBV) or ...
They also look for certain changes in the cancer cells and determine whether the leukemia cells began from B lymphocytes or T lymphocytes. This information ...
... cells. The results that we are seeing are truly unprecedented, especially in B-cell leukemias and lymphomas. Some patients who really have no other hope are ...
Bruce Levine, Ph.D. "CAR-T cells targeted to advanced B-cell leukemias and lymphomas have induced complete responses — killed cancer cells — in ...
... b-cell lymphoma, Diffuse large b-cell lymphoma, Follicular lymphoma, B-cell lymphoma, T-cell lymphoma. Show more areas of focus for Muhamad Alhaj Moustafa ...
... cell lymphoma; Splenic marginal zone B-cell lymphoma; Small lymphocytic lymphoma; Study 3- Uncommon lymphomas: Peripheral T cell lymphoma, unspecified ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.